Incorporation of laser medical equipment and a sales network through the acquisition of Asuka Medical as a wholly owned subsidiary
First written in FY2026-H1. 3 of 5 entries say "Achieved", first in 2026-08-13. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AchievedAnnual report
「The Group made 飛鳥メディカル株式会社, an affiliated company engaged in the development, manufacture, sale and maintenance of therapeutic laser medical devices, a wholly owned subsidiary,」
The voting rights ratio in 飛鳥メディカル was increased from 39.7% to 100%, completing its conversion into a wholly owned subsidiary. - FY2026-H1First statedAnnual report
「Asuka Medical’s laser scalpel is currently a key device in photoimmunotherapy, which we are currently conducting clinical trials for, and we believe that Asuka Medical’s nationwide veterinary hospital network will contribute to our future growth strategy, including M&A and product sales. We therefore decided to acquire the shares with the aim of making it a wholly owned subsidiary, further strengthening collaboration and accelerating our growth strategy.」
A business combination was completed on 1 November 2025, increasing the voting rights ratio from 39.7% to 100%. The objectives include using the laser scalpel, photoimmunotherapy, and the network for M&A and product sales.